Aaron G.L. Fletcher
CIK 1789490 · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AZTR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BOSTON, MA 02135
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACTU | Director | 60,973 | $0.39 | $23.8K | $5.00M | 3 | 2026-05-22 |
| CGTX | Director | 475,155 | $0.73 | $348.5K | $2.28M | 2 | 2025-09-23 |
| AZTR | 10%+ Owner | 68 | $1.10 | $75 | $24.00M | 1 | 2023-06-23 |
| CUE | Director | 36,833 | $18.22 | $671.1K | $4.48M | 9 | 2023-01-05 |
| TFF Pharmaceuticals, Inc. (TFFP) Delisted | Director | 10,123 | $0.07 | $658 | $4.40M | 11 | 2022-12-30 |
| SWK Holdings Corp (SWKH) Delisted | Director | 9,873 | $15.90 | $157.0K | $0 | 9 | 2022-01-12 |
| INAB | 10%+ Owner | 62,554 | $0.99 | $61.6K | $0 | 2 | 2021-08-17 |
Recent Filings · Page 3 of 4
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-04-01 | SWK Holdings Corp (SWKH) Delisted | Grant (A) | +250 | $0 | EDGAR |
| 2021-01-06 | CUE | Grant (A) | — | $0 | EDGAR |
| 2021-01-04 | SWK Holdings Corp (SWKH) Delisted | Grant (A) | +250 | $0 | EDGAR |
| 2020-11-25 | CUE | Buy (P) | +6,548 | $82.8K | EDGAR |
| 2020-11-24 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Buy (P) | +5,000 | $75.7K | EDGAR |
| 2020-10-01 | SWK Holdings Corp (SWKH) Delisted | Grant (A) | +1,911 | $0 | EDGAR |
| 2020-08-26 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-02 | SWK Holdings Corp (SWKH) Delisted | Grant (A) | +1,419 | $0 | EDGAR |
| 2020-06-25 | CUE | Buy (P) | +7,500 | $186.6K | EDGAR |
| 2020-05-26 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Buy (P) | +20,000 | $101.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.